Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy

Mayo Clinic Proceedings

Volumn 76, Issue 11, 2001, Pages 1171-1175

  Razonable, R R ^a   Aksamit, Allen J ^a   Wright, Alan J ^a   Wilson, John W ^a  

^a MAYO CLINIC   (United States)

Author keywords

AIDS = acquired immunodeficiency syndrome; CSF = cerebrospinal fluid; HAART = highly active antiretroviral therapy; HIV = human immunodeficiency virus; JCV = JC virus; MRI = magnetic resonance imaging; PCR = polymerase chain reaction; PI = protease inhibitor; PML = progressive multifocal leukoencephalopathy

Indexed keywords

ANTIRETROVIRUS AGENT; CIDOFOVIR; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; DEMYELINATING DISEASE; HUMAN; IMMUNE RESPONSE; JC VIRUS; MALE; OPPORTUNISTIC INFECTION; PATHOGENESIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0034759956     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.11.1171     Document Type: Article

References (17)

1. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy
2. Activities of various compounds against murine and primate polyomaviruses
3. Natural history of HIV infection in the era of combination antiretroviral therapy
4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
5. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV cohort study
6. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy
7. Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy
8. New treatments for progressive multifocal leukoencephalopathy in HIV-1-infected patients
9. Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside
10. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy
11. Subclinical central nervous system infection with JC virus in patients with AIDS
12. Paradoxical worsening of AIDS-associated progressive multifocal leukoencephalopathy following HAART
13. Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy
14. Monitoring the response of AIDS-related progressive multifocal leukoencephalopathy to HAART and cidofovir by PCR for JC virus DNA in the CSF
15. The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line
16. Prospective pilot study of cidofovir for HIV-associated progressive multifocal leukoencephalopathy (PML)
17. Clinical course and prognostic factors of AIDS-associated progressive multifocal leukoencephalopathy (PML) in patients treated with HAART (GESIDA 11/99)